Danielle R. Fixen

613 total citations
26 papers, 412 citations indexed

About

Danielle R. Fixen is a scholar working on Geriatrics and Gerontology, Epidemiology and Pharmacology. According to data from OpenAlex, Danielle R. Fixen has authored 26 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Geriatrics and Gerontology, 6 papers in Epidemiology and 5 papers in Pharmacology. Recurrent topics in Danielle R. Fixen's work include Pharmaceutical Practices and Patient Outcomes (8 papers), Medication Adherence and Compliance (3 papers) and Cannabis and Cannabinoid Research (3 papers). Danielle R. Fixen is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (8 papers), Medication Adherence and Compliance (3 papers) and Cannabis and Cannabinoid Research (3 papers). Danielle R. Fixen collaborates with scholars based in United States. Danielle R. Fixen's co-authors include Sunny A. Linnebur, B. Parnes, Joseph J. Saseen, Gretchen M. Orosz, Laura Saba, Hillary D. Lum, Skotti Church, Kevin T. Kavanagh, Joseph P. Vande Griend and Amanda Mueller and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Geriatrics Society and Journal of General Internal Medicine.

In The Last Decade

Danielle R. Fixen

25 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danielle R. Fixen United States 10 83 83 82 79 58 26 412
Francesco Paris Italy 13 71 0.9× 92 1.1× 174 2.1× 136 1.7× 43 0.7× 19 622
Javier García del Pozo Spain 12 75 0.9× 38 0.5× 47 0.6× 26 0.3× 35 0.6× 33 455
Christopher M. Herndon United States 15 146 1.8× 96 1.2× 171 2.1× 31 0.4× 30 0.5× 46 875
Miia Tiihonen Finland 15 24 0.3× 136 1.6× 80 1.0× 67 0.8× 42 0.7× 67 664
Randall D. Seifert United States 12 63 0.8× 35 0.4× 159 1.9× 29 0.4× 33 0.6× 32 465
Anicet Chaslerie France 11 64 0.8× 90 1.1× 22 0.3× 13 0.2× 45 0.8× 28 480
Jeffrey Fudin United States 17 153 1.8× 38 0.5× 167 2.0× 83 1.1× 60 1.0× 50 900
Yu-Wen Wen Taiwan 15 46 0.6× 233 2.8× 70 0.9× 25 0.3× 52 0.9× 24 659
Mark E. Lehman United States 5 90 1.1× 220 2.7× 42 0.5× 32 0.4× 34 0.6× 7 577
Stefano Berterame Austria 4 70 0.8× 43 0.5× 93 1.1× 22 0.3× 92 1.6× 7 602

Countries citing papers authored by Danielle R. Fixen

Since Specialization
Citations

This map shows the geographic impact of Danielle R. Fixen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle R. Fixen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle R. Fixen more than expected).

Fields of papers citing papers by Danielle R. Fixen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle R. Fixen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle R. Fixen. The network helps show where Danielle R. Fixen may publish in the future.

Co-authorship network of co-authors of Danielle R. Fixen

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle R. Fixen. A scholar is included among the top collaborators of Danielle R. Fixen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle R. Fixen. Danielle R. Fixen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Linnebur, Sunny A., et al.. (2025). A Case of Semaglutide-Induced Skin Burning. SHILAP Revista de lepidopterología. 4(3). 1 indexed citations
2.
Billups, Sarah J., et al.. (2023). Patient Perception and Impact of Home Test Kits on Health Care Utilization for Urinary Tract Infection. Population Health Management. 27(1). 44–48. 1 indexed citations
3.
Billups, Sarah J., et al.. (2023). Lessons Learned: Evaluation of Fracture Liaison Service Quality Improvement Efforts in a Large Academic Healthcare System. Journal of General Internal Medicine. 39(8). 1407–1413. 2 indexed citations
4.
Fixen, Danielle R., et al.. (2022). Renal safety of zoledronic acid for osteoporosis in adults 75 years and older. Osteoporosis International. 33(11). 2417–2422. 12 indexed citations
5.
Chauhan, Lakshmi, Mona Abdo, Skotti Church, et al.. (2022). Impact of a pilot multimodal intervention to decrease antibiotic use for respiratory infections in a geriatric clinic. SHILAP Revista de lepidopterología. 2(1). e1–e1. 1 indexed citations
6.
Fixen, Danielle R., et al.. (2022). Multidisciplinary Approach to Deprescribing Sedative-Hypnotic Medications in Geriatric Primary Care. Journal of Primary Care & Community Health. 13. 4267723576–4267723576. 6 indexed citations
7.
Linnebur, Sunny A., et al.. (2021). Implementation of Pharmacist Reviews to Screen for Potentially Inappropriate Medications in Patients With Cognitive Impairment. The Senior Care Pharmacist. 36(10). 508–522. 5 indexed citations
8.
Fixen, Danielle R., et al.. (2021). Cognitive effects of vortioxetine in older adults: a systematic review. SHILAP Revista de lepidopterología. 11. 1926944108–1926944108. 24 indexed citations
9.
Fixen, Danielle R., et al.. (2021). Cannabis for Chronic Osteoarthritis Pain: A Case of an Older Person. The Senior Care Pharmacist. 36(7). 337–342. 3 indexed citations
10.
Fixen, Danielle R., et al.. (2020). Pharmacist-Led Transition of Care Pilot Targeting Older People After Emergency Department Discharge. The Senior Care Pharmacist. 35(6). 273–282. 3 indexed citations
11.
Mueller, Amanda & Danielle R. Fixen. (2020). Use of Cannabis for Agitation in Patients With Dementia. The Senior Care Pharmacist. 35(7). 312–317. 5 indexed citations
12.
Linnebur, Sunny A., et al.. (2019). Optimal Melatonin Dose in Older Adults: A Clinical Review of the Literature. The Senior Care Pharmacist. 34(7). 419–431. 17 indexed citations
13.
Linnebur, Sunny A., et al.. (2019). Effects of Chronic Proton-Pump Inhibitor Use on Kidney Function in Older Adults. The Senior Care Pharmacist. 34(5). 325–333. 2 indexed citations
14.
Kavanagh, Kevin T., et al.. (2019). Evaluation of methenamine for urinary tract infection prevention in older adults: a review of the evidence. Therapeutic Advances in Drug Safety. 10. 584418701–584418701. 20 indexed citations
15.
Fixen, Danielle R.. (2019). 2019 AGS Beers Criteria for older adults. Pharmacy Today. 25(11). 42–54. 19 indexed citations
16.
Linnebur, Sunny A., et al.. (2019). Effectiveness of Methenamine for UTI Prevention in Older Adults. Annals of Pharmacotherapy. 54(4). 359–363. 5 indexed citations
17.
Linnebur, Sunny A., et al.. (2018). Evaluating the risk of QTc prolongation associated with antidepressant use in older adults: a review of the evidence. Therapeutic Advances in Drug Safety. 9(6). 297–308. 31 indexed citations
18.
Fixen, Danielle R., et al.. (2018). Dofetilide-induced anorexia in an older adult. Therapeutic Advances in Drug Safety. 9(7). 367–372.
19.
Fixen, Danielle R., et al.. (2018). Development and economic evaluation of a pharmacist-provided chronic care management service in an ambulatory care geriatrics clinic. American Journal of Health-System Pharmacy. 75(22). 1805–1811. 18 indexed citations
20.
Fixen, Danielle R., et al.. (2017). Zolpidem prescribing practices before and after Food and Drug Administration required product labeling changes. SAGE Open Medicine. 5. 2104779687–2104779687. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Paris Breakdown of academic impact, for papers by Javier García del Pozo Breakdown of academic impact, for papers by Christopher M. Herndon Breakdown of academic impact, for papers by Miia Tiihonen Breakdown of academic impact, for papers by Randall D. Seifert Breakdown of academic impact, for papers by Anicet Chaslerie Breakdown of academic impact, for papers by Jeffrey Fudin Breakdown of academic impact, for papers by Yu-Wen Wen Breakdown of academic impact, for papers by Mark E. Lehman Breakdown of academic impact, for papers by Stefano Berterame
Rankless by CCL
2026